Atricure Inc. buy Needham & Company LLC
Start price
03.11.23
/
50%
€36.20
Target price
03.11.24
€45.71
Performance (%)
-
End price
04.11.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 2.941% | 2.941% | -43.548% |
| iShares Core DAX® | 2.659% | 4.844% | 23.110% |
| iShares Nasdaq 100 | 0.916% | -0.554% | 6.985% |
| iShares Nikkei 225® | 2.426% | 1.598% | 15.780% |
| iShares S&P 500 | 1.230% | 1.039% | 4.695% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at Needham & Company LLC from $68.00 to $49.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten

